11-36574650-G-A

Variant summary

Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BS2_SupportingBA1

This summary comes from the ClinGen Evidence Repository: The NM_000448.3:c.1346G>A variant in RAG1 is a missense variant predicted to cause the substitution of Arginine by Lysine at amino acid 449 (p.Arg449Lys). The filtering allele frequency (the lower threshold of the 95% CI of 21803/1180030) of the c.1346G>A variant in RAG1 is 0.01837 for European (non-Finnish) chromosomes by gnomAD v.4, which is higher than the ClinGen SCID VCEP threshold (>0.00872) for BA1 and, therefore, meets this criterion (BA1). Additionally, 207 homozygous adults are reported on gnomAD v.4 (BS2_Supporting). In summary, this variant meets the criteria to be classified as Benign for autosomal recessive SCID. ACMG/AMP criteria applied, as specified by the ClinGen SCID-VCEP: BA1 and BS2_Supporting. (VCEP specifications version 1). LINK:https://erepo.genome.network/evrepo/ui/classification/CA5950130/MONDO:0000572/123

Frequency

Genomes: 𝑓 0.010 ( 17 hom., cov: 33)
Exomes 𝑓: 0.015 ( 190 hom. )

Consequence

RAG1
NM_000448.3 missense

Scores

5
13

Clinical Significance

Benign reviewed by expert panel U:1B:8

Conservation

PhyloP100: 4.40
Variant links:
Genes affected
RAG1 (HGNC:9831): (recombination activating 1) The protein encoded by this gene is involved in activation of immunoglobulin V-D-J recombination. The encoded protein is involved in recognition of the DNA substrate, but stable binding and cleavage activity also requires RAG2. Defects in this gene can be the cause of several diseases. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -9 ACMG points.

BS2
For more information check the summary or visit ClinGen Evidence Repository.
BA1
For more information check the summary or visit ClinGen Evidence Repository.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
RAG1NM_000448.3 linkuse as main transcriptc.1346G>A p.Arg449Lys missense_variant 2/2 ENST00000299440.6 NP_000439.2

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
RAG1ENST00000299440.6 linkuse as main transcriptc.1346G>A p.Arg449Lys missense_variant 2/21 NM_000448.3 ENSP00000299440 P1P15918-1

Frequencies

GnomAD3 genomes
AF:
0.0102
AC:
1554
AN:
152224
Hom.:
17
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00287
Gnomad AMI
AF:
0.0527
Gnomad AMR
AF:
0.00772
Gnomad ASJ
AF:
0.00115
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.00103
Gnomad FIN
AF:
0.0107
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0167
Gnomad OTH
AF:
0.00430
GnomAD3 exomes
AF:
0.00975
AC:
2446
AN:
250856
Hom.:
20
AF XY:
0.00963
AC XY:
1306
AN XY:
135560
show subpopulations
Gnomad AFR exome
AF:
0.00345
Gnomad AMR exome
AF:
0.00249
Gnomad ASJ exome
AF:
0.00239
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00118
Gnomad FIN exome
AF:
0.0132
Gnomad NFE exome
AF:
0.0169
Gnomad OTH exome
AF:
0.00735
GnomAD4 exome
AF:
0.0154
AC:
22480
AN:
1461880
Hom.:
190
Cov.:
36
AF XY:
0.0149
AC XY:
10859
AN XY:
727242
show subpopulations
Gnomad4 AFR exome
AF:
0.00242
Gnomad4 AMR exome
AF:
0.00264
Gnomad4 ASJ exome
AF:
0.00199
Gnomad4 EAS exome
AF:
0.0000252
Gnomad4 SAS exome
AF:
0.00123
Gnomad4 FIN exome
AF:
0.0144
Gnomad4 NFE exome
AF:
0.0186
Gnomad4 OTH exome
AF:
0.0113
GnomAD4 genome
AF:
0.0102
AC:
1553
AN:
152342
Hom.:
17
Cov.:
33
AF XY:
0.00949
AC XY:
707
AN XY:
74496
show subpopulations
Gnomad4 AFR
AF:
0.00286
Gnomad4 AMR
AF:
0.00771
Gnomad4 ASJ
AF:
0.00115
Gnomad4 EAS
AF:
0.000193
Gnomad4 SAS
AF:
0.00104
Gnomad4 FIN
AF:
0.0107
Gnomad4 NFE
AF:
0.0167
Gnomad4 OTH
AF:
0.00425
Alfa
AF:
0.0135
Hom.:
33
Bravo
AF:
0.0100
TwinsUK
AF:
0.0178
AC:
66
ALSPAC
AF:
0.0189
AC:
73
ESP6500AA
AF:
0.00250
AC:
11
ESP6500EA
AF:
0.0142
AC:
122
ExAC
AF:
0.0104
AC:
1266
Asia WGS
AF:
0.000577
AC:
2
AN:
3478
EpiCase
AF:
0.0125
EpiControl
AF:
0.0145

ClinVar

Significance: Benign
Submissions summary: Uncertain:1Benign:8
Revision: reviewed by expert panel
LINK: link

Submissions by phenotype

not provided Benign:3
Benign, criteria provided, single submitterclinical testingARUP Laboratories, Molecular Genetics and Genomics, ARUP LaboratoriesOct 25, 2022- -
Benign, criteria provided, single submitterclinical testingGeneDxMar 03, 2015This variant is associated with the following publications: (PMID: 24290284, 21228398, 16960852, 27609655, 33046446) -
Likely benign, criteria provided, single submitterclinical testingCeGaT Center for Human Genetics TuebingenJul 01, 2024RAG1: PM5, BS1, BS2 -
not specified Benign:2
Benign, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact Sciences-- -
Benign, criteria provided, single submitterclinical testingWomen's Health and Genetics/Laboratory Corporation of America, LabCorpSep 11, 2019Variant summary: RAG1 c.1346G>A (p.Arg449Lys) results in a conservative amino acid change located in the RAG nonamer-binding domain of the encoded protein sequence. Three of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 0.0098 in 250856 control chromosomes, predominantly at a frequency of 0.017 within the Non-Finnish European subpopulation in the gnomAD database, including 20 homozygotes. The observed variant frequency within Non-Finnish European control individuals in the gnomAD database is approximately 24-folds over the estimated maximal expected allele frequency for a pathogenic variant in RAG1 causing Severe Combined Immunodeficiency Syndrome/Omenn Syndrome phenotype (0.00071), strongly suggesting that the variant is a benign polymorphism found primarily in populations of Non-Finnish European origin. c.1346G>A has been reported in the literature in individuals affected with Severe Combined Immunodeficiency Syndrome/Omenn Syndrome (Haq_2007, Sobacchi_2006, Lee_2014, Kumanovics_2017). These reports do not provide unequivocal conclusions about association of the variant with Severe Combined Immunodeficiency Syndrome/Omenn Syndrome. Co-occurrences with RAG1 pathogenic variants in cis have been reported (R404Q and R410Q), providing supporting evidence for a benign role. Functional study, Lee_2014, found the variant to have comparable levels to wild type for recombination activity. A ClinVar submission (evaluation after 2014) cites the variant as benign. Based on the evidence outlined above, the variant was classified as benign. -
Histiocytic medullary reticulosis Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaApr 27, 2017This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. However, the evidence from the literature, in combination with allele frequency data from public databases where available, was not sufficient to rule this variant in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. -
Recombinase activating gene 1 deficiency Benign:1
Benign, reviewed by expert panelcurationClinGen Severe Combined Immunodeficiency Variant Curation Expert Panel, ClinGenJan 23, 2024The NM_000448.3:c.1346G>A variant in RAG1 is a missense variant predicted to cause the substitution of Arginine by Lysine at amino acid 449 (p.Arg449Lys). The filtering allele frequency (the lower threshold of the 95% CI of 21803/1180030) of the c.1346G>A variant in RAG1 is 0.01837 for European (non-Finnish) chromosomes by gnomAD v.4, which is higher than the ClinGen SCID VCEP threshold (>0.00872) for BA1 and, therefore, meets this criterion (BA1). Additionally, 207 homozygous adults are reported on gnomAD v.4 (BS2_Supporting). In summary, this variant meets the criteria to be classified as Benign for autosomal recessive SCID. ACMG/AMP criteria applied, as specified by the ClinGen SCID-VCEP: BA1 and BS2_Supporting. (VCEP specifications version 1). -
Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-positive Benign:1
Likely benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaApr 27, 2017This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases allowed determination this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. -
Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-positive;C2673536:Combined immunodeficiency with skin granulomas Benign:1
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 31, 2024- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.11
BayesDel_addAF
Benign
-0.44
T
BayesDel_noAF
Benign
-0.39
CADD
Benign
23
DANN
Benign
0.97
DEOGEN2
Uncertain
0.61
D
Eigen
Uncertain
0.22
Eigen_PC
Benign
0.20
FATHMM_MKL
Uncertain
0.92
D
LIST_S2
Benign
0.85
T
MetaRNN
Benign
0.0096
T
MetaSVM
Benign
-0.43
T
MutationAssessor
Benign
1.5
L
MutationTaster
Benign
0.95
D
PrimateAI
Uncertain
0.66
T
PROVEAN
Benign
-1.1
N
REVEL
Uncertain
0.31
Sift
Benign
0.048
D
Sift4G
Benign
0.13
T
Polyphen
0.95
P
Vest4
0.091
MPC
0.62
ClinPred
0.052
T
GERP RS
3.8
Varity_R
0.10
gMVP
0.49

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs4151031; hg19: chr11-36596200; COSMIC: COSV104408609; COSMIC: COSV104408609; API